BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18298517)

  • 1. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
    Rassi A
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators.
    Sarabanda AV; Marin-Neto JA
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):54-62. PubMed ID: 20946310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.
    Cardinalli-Neto A; Greco OT; Bestetti RB
    Pacing Clin Electrophysiol; 2006 May; 29(5):467-70. PubMed ID: 16689840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator.
    Bruch C; Bruch C; Sindermann J; Breithardt G; Gradaus R
    Europace; 2007 Aug; 9(8):681-6. PubMed ID: 17507354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.
    Salles G; Xavier S; Sousa A; Hasslocher-Moreno A; Cardoso C
    Circulation; 2003 Jul; 108(3):305-12. PubMed ID: 12835217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.
    di Toro D; Muratore C; Aguinaga L; Batista L; Malan A; Greco O; Benchetrit C; Duque M; Baranchuk A; Maloney J
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1063-9. PubMed ID: 21535031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
    Huikuri HV
    Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.
    Schefer T; Wolber T; Binggeli C; Holzmeister J; Brunckhorst C; Duru F
    Europace; 2008 Sep; 10(9):1052-9. PubMed ID: 18687703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.
    Pereira FT; Rocha EA; Monteiro Mde P; Neto AC; Daher Ede F; Sobrinho CR; Pires Neto Rda J
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):751-6. PubMed ID: 24467488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease.
    Borleffs CJ; van Welsenes GH; van Bommel RJ; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Rosendaal FR; Schalij MJ
    Eur Heart J; 2010 Mar; 31(6):712-8. PubMed ID: 19933693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.